SEC 13F Intelligence

Banco Bilbao Vizcaya Argentaria, S.A. / REGN

Banco Bilbao Vizcaya Argentaria, S.A.’s Regeneron Pharmaceuticals Position

Does Banco Bilbao Vizcaya Argentaria, S.A. own Regeneron Pharmaceuticals (REGN)? Yes — 16.1K shares worth $12M (+0.09% of its 13F portfolio) as of Q1 2026, down from 36.0K shares the prior filed quarter.

Position Value
$12M
Q1 2026
Shares
16.1K
% of Portfolio
+0.09%
Quarters Held
26
currently held

Position History REGN

Reported value by quarter
Q4 ’19: $328,000Q4 ’19Q1 ’20: $465,000Q2 ’20: $2MQ3 ’20: $2MQ4 ’20: $2MQ4 ’20Q1 ’21: $1MQ2 ’21: $4MQ3 ’21: $6MQ4 ’21: $19MQ4 ’21Q1 ’22: $23MQ2 ’22: $26MQ3 ’22: $27MQ4 ’22: $29MQ4 ’22Q1 ’23: $33MQ2 ’23: $30MQ3 ’23: $33MQ4 ’23: $35MQ4 ’23Q1 ’24: $39MQ2 ’24: $44MQ3 ’24: $40MQ4 ’24: $27MQ4 ’24Q1 ’25: $24MQ2 ’25: $20MQ3 ’25: $21MQ4 ’25: $28MQ4 ’25Q1 ’26: $12Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202616.1K$12M+0.09%
Q4 202536.0K$28M+0.19%
Q3 202537.6K$21M+0.16%
Q2 202537.7K$20M+0.18%
Q1 202538.2K$24M+0.24%
Q4 202437.5K$27M+0.28%
Q3 202437.7K$40M+0.40%
Q2 202441.6K$44M+0.55%
Q1 202440.6K$39M+0.53%
Q4 202340.1K$35M+0.49%
Q3 202340.7K$33M+0.45%
Q2 202341.5K$30M+0.39%
Q1 202340.0K$33M+0.41%
Q4 202240.6K$29M+0.43%
Q3 202239.6K$27M+0.44%
Q2 202243.5K$26M+0.39%
Q1 202232.5K$23M+0.31%
Q4 202129.5K$19M+0.25%
Q3 202110.0K$6M+0.10%
Q2 20217.0K$4M+0.07%
Q1 20212.8K$1M+0.03%
Q4 20204.8K$2M+0.05%
Q3 20204.2K$2M+0.07%
Q2 20203.8K$2M+0.08%
Q1 2020953$465,000+0.02%
Q4 2019875$328,000+0.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Banco Bilbao Vizcaya Argentaria, S.A.’s full portfolio or all institutional holders of REGN.